In 2016, more than 42,000 lives were lost due to opioid overdose. The opioid epidemic is now one of the most pressing public health questions facing the nation. Current treatments
The Coalition for the Life Sciences (CLS) is extremely grateful to Congress for the bold vision to generously increase support for the federally funded life science research this year with
Dr. Namandjé Bumpus discusses the ways that people can respond to a drug. While many drugs are available as “one size fits all” regimens, all drugs do not work the
Representing more than 60,000 federally funded scientists across the country in every state, the Coalition for the Life Sciences (CLS) urges Congress to finalize a budget agreement and pass an
The Coalition for the Life Sciences (CLS) is very concerned with provisions in HR 1, the Tax Cuts and Jobs Act, that will adversely affect the biomedical enterprise. Congress has
There is hardly a worse diagnosis for parents to receive than “your child has cancer.” What may be even worse is if one’s other children are also diagnosed with cancer.
An estimated 5.5 million people in the U.S. suffer from Alzheimer’s disease or some other form of dementia. The number is expected to double every 20 years as life expectancy
The National Institutes of Health is the world’s leading supporter of fundamental discovery that extends healthy lives and reduces the burden of illness. Thanks to the Congressional investment, NIH-supported research
The Senate Appropriations subcommittee covering health and human services expressed broad, bipartisan support for continued funding of the National Institutes of Health (NIH) in a hearing last Thursday with Dr.
Pioneering autism researcher, Matthew State, MD, PhD, discusses the profound scientific opportunities that are rapidly accelerating progress in autism research. The advent of genome sequencing has allowed researchers to make